Emerging roles and opportunities for rare disease patient advocacy groups.

Patterson, Amy M; O'Boyle, Megan; VanNoy, Grace E; Dies, Kira A

Patterson, Amy M; O'Boyle, Megan; VanNoy, Grace E; Dies, Kira A.

Afiliación

Patterson AM; Department of Genetic Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA.
O'Boyle M; Coalition of Patient Advocacy Groups, Rare Diseases Clinical Research Network, Arlington, VA, USA.
VanNoy GE; Center for Mendelian Genomics and Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Dies KA; Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Boston, MA, USA.

Ther Adv Rare Dis ; 4: 26330040231164425, 2023.

Article en En | MEDLINE | ID: mdl-37197559

Palabras clave

clinical trial; drug development; patient advocacy group; registry; research; support

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Qualitative_research / Risk_factors_studies Idioma: En Revista: Ther Adv Rare Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google